Homepage
Author:
Klothea Bio, Inc.
Posted Date:
February 19, 2026
Klothea Bio Announces the Launch of a Phase 1b Clinical Trial of AKL003, an Alpha Klotho mRNA Therapeutic, for the Extension of Human Lifespan
Klothea Bio, Inc.
February 19, 2026